Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Novavax Community
NasdaqGS:NVAX Community
1
Narratives
written by author
0
Comments
on narratives written by author
81
Fair Values set
on narratives written by author
Create a narrative
Novavax
Popular
Undervalued
Overvalued
Community Investing Ideas
Novavax
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Sanofi Partnership And Pipeline Programs Will Expand Future Markets
Key Takeaways Strategic partnerships and new vaccine programs could significantly boost Novavax's future revenue and market expansion efforts. Cost reduction initiatives and asset sales aim to improve profitability and enhance operating margins by optimizing resource allocation.
View narrative
US$16.14
FV
58.7% undervalued
intrinsic discount
-22.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
NVAX
NVAX
Novavax
Your Fair Value
US$
Current Price
US$6.67
41.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-2b
2b
2015
2018
2021
2024
2025
2027
2030
Revenue US$377.8m
Earnings US$74.0m
Advanced
Set Fair Value